Skip to content
10-K

Annual Report

NUTEX HEALTH INC. NUTX

0001628280-26-015168

← back to feed
Filed
Mar 5, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 2, 2026 6.97M sh
Shares Diluted FY 2025 · Dec 31, 2025 6.76M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $5M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $2.53M
Operating Cash Flow FY 2025 · Dec 31, 2025 $248.13M
Long Term Debt FY 2025 · Dec 31, 2025 $29.17M
Cash And Equivalents FY 2025 · Dec 31, 2025 $185.57M
Cash And Equivalents restated FY 2025 · Dec 31, 2022 $34.26M
Stockholders Equity FY 2025 · Dec 31, 2025 $329.45M
Current Liabilities FY 2025 · Dec 31, 2025 $157.91M
Total Liabilities FY 2025 · Dec 31, 2025 $495.09M
Current Assets FY 2025 · Dec 31, 2025 $538.81M
Total Assets FY 2025 · Dec 31, 2025 $918.53M
Eps Diluted FY 2025 · Dec 31, 2025 $10.48
Eps Basic FY 2025 · Dec 31, 2025 $11.13
Sga Expense FY 2025 · Dec 31, 2025 $51.65M
Net Income FY 2025 · Dec 31, 2025 $70.79M
Operating Income FY 2025 · Dec 31, 2025 $275.63M
Gross Profit FY 2025 · Dec 31, 2025 $444.28M